Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study.
Keiko TanimuraTakayuki TakedaAkihiro YoshimuraRyoichi HondaShiho GodaShinsuke ShiotsuMototaka FukuiYusuke ChiharaKiyoaki UryuShota TakeiYuki KatayamaMakoto HibinoTadaaki YamadaTakayama KoichiPublished in: Cancers (2023)
Combining pre-CRT mGPS values with post-CRT CRP levels in patients with locally advanced NSCLC helps to predict the PFS and OS of durvalumab consolidation after CRT.